All Categories
Business
Entertainment
Health
Finance
Other
Category
Medicine and Healthcare
Press Release
Aug 22, 2025
EyeFortin Review 2025: Natural Eye Drops for Vision Support, Clarity, and Daily Eye Health
Plant-Based Formula Backed by Key Nutrients for Eye Function, Brain-Eye Signaling, and Screen-Time Vision Care
Read More
Press Release
Aug 22, 2025
Arthrocel Review 2025: Natural Joint Support With UC-II Collagen
Natural joint support combining UC-II Collagen, Glucosamine, Malate Magnesium, and Indonesian Curcumin for ongoing mobility and reduced stiffness in 2025
Read More
Press Release
Aug 22, 2025
DigestiStart Under Review: Natural Digestive Health Supplement for Bloating, Gut Balance, and Daily Comfort
DigestiStart supports smoother digestion, eases bloating, and helps maintain gut balance with a natural formulation tailored for daily comfort
Read More
Press Release
Aug 22, 2025
Emergency Care Partners and TEA Unite to Strengthen Emergency Medicine Services in Arizona
Read More
Press Release
Aug 22, 2025
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Read More
Press Release
Aug 22, 2025
Medical Care Technologies Inc. (OTC Pink:MDCE) Powers Forward in 2025 With Patent-Pending AI, Explosive Revenue Growth, and Historic Auction Showcase
Rebounding with Strength: AI Innovation, Health Care Tools and Sports Legacy Drive MDCE's Expansion
Read More
Press Release
Aug 22, 2025
Bionic Bloom Unveils Neurodivergent Burnout IOP: An Empowerment-Based Pathway to Restore Energy, Focus, and Joy
Read More
Press Release
Aug 21, 2025
Forum Health and Steer Health Join Forces to Lead AI-Powered Advancements in Functional Medicine
Partnership aims to scale personalized, root-cause care with AI automation while preserving the patient-first approach of functional medicine.
Read More
Press Release
Aug 21, 2025
ZetrOZ Systems' sam Wearable Ultrasound Device Helps Medtech CEO Relieve Back Pain and Get Back to Work
Sustained acoustic medicine provided Lia Winter with a way to recover quickly without the need for invasive surgery to repair a herniated cervical disc.
Read More
Press Release
Aug 21, 2025
Glidewell Launches BruxZir(R) Glass Restorations
Bilayered BruxZir® restoration offers results virtually indistinguishable from natural teeth
Read More
Press Release
Aug 21, 2025
The Ridge RTC Welcomes Two New Behavioral Health Advisors
The new advisors will provide guidance and support to Ridge RTC residents while also spreading awareness about the need for high-quality teen behavioral health and substance use treatment
Read More
Press Release
Aug 21, 2025
ISPOR's Oncology and Statistical Methods Special Interest Groups Selects DistillerSR for Joint Systematic Review Project
Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR.
Read More
Press Release
Aug 21, 2025
Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs
Canalevia® (crofelemer delayed-release tablets), under the name Canalevia®-CA1, is conditionally approved by the FDA for treatment of CID in dogs Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment of general diarrhea globally Diarrhea is one of the most common reasons owners bring their dog to the veterinarian and the second most common reason for visits to the veterinary emergency hospital, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs Enrollment has reached approximately 25% in Jaguar's ongoing field study of Canalevia-CA1 in dogs
Read More
Press Release
Aug 21, 2025
Pace Life Sciences' San Germán Site Receives Positive Inspection From FDA
Company commitment to quality excellence confirmed during FDA Inspection
Read More
Press Release
Aug 21, 2025
Sound Physicians Unveils New Brand Identity, Reflecting More Than Two Decades of Patient-Centric Partnership and a Bold Vision for the Future
The Physician-Led Medical Group is Committed to Building Exceptional Partnerships and Enhancing Health in the Communities They Serve While Lessening the Burden of Care on Clinicians and Patients
Read More
Press Release
Aug 21, 2025
The Billionaire Face is Real-But It's Not What You Think, Says Top Facial Plastic Surgeon Dr. Shervin Naderi
From six-figure facelifts to overfilled mistakes, the "Mar-a-Lago Face" comes in two very different forms-and only one of them is truly elite.
Read More
Press Release
Aug 21, 2025
Moderna to Present at Upcoming Conferences in September 2025
Read More
Press Release
Aug 21, 2025
Bionic Bloom Launches Suite of Intensive Outpatient Programs Focused on Personalized, Integrative Care
Read More
Press Release
Aug 20, 2025
VisiPure Review 2025: Eye Health Supplement for Vision Support
VisiPure combines antioxidants and plant‑based compounds to support healthy circulation, protect against oxidative stress, and help maintain visual clarity for those experiencing eye fatigue and screen‑induced strain.
Read More
Press Release
Aug 20, 2025
Best Pineal Gland Supplement Reviews 2025: Expert Insights, Research, and Real User Experiences
Enki Elixir supports clarity, energy, and natural balance-this guide explains how leading pineal‑support formulas work, compares top options, and shares expert analysis and user experiences.
Read More
Press Release
Aug 20, 2025
Best Glucose Support Supplement 2025: Glucorem Review
Glucorem liquid tincture supports glucose balance, insulin sensitivity, and sustained energy through fast-absorbing sublingual delivery
Read More
Press Release
Aug 20, 2025
Neurocare Group Receives FDA Clearance for Treatment of OCD With Its Transcranial Magnetic Stimulation (TMS) Devices
neurocare's Apollo TMS Therapy systems are now FDA-cleared for the treatment of Obsessive Compulsive Disorder, offering a new non-drug treatment option for patients and providers.
Read More
Press Release
Aug 20, 2025
BrainAMP Review 2025: Advanced BioNutritionals Memory & Focus Supplement
A doctor‑developed nootropic formula that supports focus, mental clarity, memory recall and cognitive performance with clinically tested ingredients.
Read More
Press Release
Aug 20, 2025
Wellgistics Health Achieves Stability in First-Half 2025 and Executes Growth Initiatives
Read More
Press Release
Aug 20, 2025
Tampa MD, PhD Meegan Gruber, Board-Certified Plastic Surgeon, Explains the Title Tricks and How to Stay Safe
"I Just Found Out My ‘Plastic Surgeon' Wasn't a Plastic Surgeon."
Read More
Press Release
Aug 20, 2025
ESSE Care Hosts Inaugural Summer Soirée: Uniting NYC's Brightest Healthcare Providers at the Shafer Clinic Sky Terrace
An Exclusive Evening of Connection Across Disciplines, Expertly Produced by Revel Rouge at The Shafer Clinic Sky Terrace
Read More
Press Release
Aug 20, 2025
Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments
Read More
Press Release
Aug 20, 2025
DEA Unconstitutional Marijuana Playbook: How the DEA Is Repeating the DOL's Mistakes Against MMJ BioPharma
"Two Federal Agencies, One Unconstitutional Playbook, all While Agency Overreach Crushes a 125 year old Family Farm and Paralyzes a Cannabis Cultivation Company for 7 years alike" says Duane Boise, CEO of MMJ International Holdings. DEA Administrator Terry Cole fix it!
Read More
Press Release
Aug 19, 2025
Bionic Bloom Chooses NBX Wellness to Offer Genetic Testing and Personalized Peptide Therapies
Read More
Press Release
Aug 19, 2025
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in US Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar's orphan indication products, resulting in non-dilutive funding for Jaguar
Read More
Press Release
Aug 19, 2025
Physicians for Informed Consent Publishes Silver Booklet, Shows Childhood Vaccines Not Proven Safer Than the Diseases They Target
Data-driven analysis compares disease risks to vaccine risks, highlighting evidence gaps and urging review of school vaccine mandates
Read More
Press Release
Aug 19, 2025
ASCP Strengthens Voice in Senior Care: Chad Worz Joins PQM PAC/LTC Committee, Along With BOD Members Rob Accetta and Rob Leffler
Read More
Press Release
Aug 19, 2025
ForCast Orthopedics Announces Expansion of Scientific Advisory Board
Read More
Press Release
Aug 19, 2025
Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval
Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships
Read More
Press Release
Aug 19, 2025
MDCE Readies Major Share Reduction After 2,500% Q2 Revenue Surge
Read More
Press Release
Aug 19, 2025
Australian Breakthrough by Cholrem: Cyclodextrin Therapy Reverses Heart Disease, Hailed as Greatest Advance Since Statins
Australian Company Announces Landmark Paper Showing Cyclodextrin Therapy Reverses Heart Disease, Hailed as ‘Greatest Development Since Statins’
Read More
Press Release
Aug 19, 2025
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating MVID patient by up to 27%; abstract describing results accepted for presentation at upcoming North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) 2025 Annual Meeting in Chicago
Read More
Press Release
Aug 19, 2025
IGC Pharma Reports First Quarter Fiscal 2026 Financial Results; Company Accelerates Phase 2 Alzheimer's Trial
Read More
Press Release
Aug 19, 2025
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025
Read More
Press Release
Aug 19, 2025
Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed, Value-Based, Data-Driven Decisions ~ ~ Ensysce Biopharma Leader to Deliver Opening Remarks and Present Case Study on Launching Successful Brands ~
Read More
Press Release
Aug 19, 2025
Say Goodbye to Itchy Skin: SilverCeuticals Launches Breakthrough FDA-Registered Eczema Therapy & Skin Relief Cream
The natural solution to skin irritation - Powered by science, nature, and silver.
Read More
Press Release
Aug 19, 2025
Pres. Trump's Chance to Fix DEA's Marijuana Policy Failures: Rescheduling?
DEA Administrator Terrance Cole has also signaled a tough line: "Everybody knows my stance on marijuana after 30 plus years in law enforcement, so don't even ask!" However, with all due respect to law enforcement, you can't fight a disease with a badge. MMJ is developing FDA regulated medicine, not an illicit substance. We are the science, and our mission is to treat patients, not to police a plant." Duane Boise, CEO MMJ International Holdings.
Read More
Press Release
Aug 18, 2025
Neuropathy Revolution Review: 7-Step Nerve Pain Solution
A seven-step digital guide outlines lifestyle changes, nutrition, and mind-body strategies for addressing peripheral neuropathy
Read More
Press Release
Aug 18, 2025
The Assistance Fund Opens New Program for Bronchiectasis
Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Bronchiectasis
Read More
Press Release
Aug 18, 2025
Society of Interventional Oncology Announces First Site Approved for Enrollment in TRIBUTE Trial
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated with Percutaneous Ablation and Palliative Radiation Therapy
Read More
Press Release
Aug 18, 2025
Concierge Care Advisors - the Nation's Premiere Care and Transitions Company Launches the Concierge Care Senior Navigator
Concierge Care Advisors Launches the Concierge Care Senior Navigator - a Free, Patent-Pending Tool for Families Navigating Senior Care
Read More
Press Release
Aug 18, 2025
MDCE Subsidiary Infinite Auctions Soars with 2,500% YoY Revenue Growth in Q2 2025
Read More
Press Release
Aug 18, 2025
A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials
Read More
Press Release
Aug 18, 2025
Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
According to the NIH, Acute myocardial infarction (AMI) is a major cause of death, affecting nearly 3 million Americans each year and resulting in over a million deaths Trial demonstrates dramatically higher and more rapid therapeutic impact compared to standard chewed aspirin tablets in clinical trial Aspire's sublingual aspirin was safe and well-tolerated Aspire plans to review clinical trial results with the FDA to enable a potential regulatory submission for accelerated approval
Read More
Press Release
Aug 17, 2025
President Trump's Marijuana Fix? DEA’s Program Exposed: Promises Made, Promises Not Kept
"As President Trump weighs marijuana rescheduling in the coming weeks, the DEA's track record reveals years of mismanagement, empty promises, and patients left waiting," stated MMJ CEO Duane Boise.
Read More
Press Release
Aug 16, 2025
Epic UGM 2025 Survival Guide: Insider Tips for Vendors, Storytellers, and Market Watchers
Black Book Research Marks Its 12th Year on the Ground in Verona with Independent, Vendor-Agnostic Insights for Navigating Epic's Provider-First Culture
Read More
Press Release
Aug 15, 2025
PureLief Review: LI4 Acupressure Device for Pain Relief & Weight Loss
PureLief targets the LI4 hand pressure point to support natural pain relief, stimulate digestion via lymphatic drainage, curb hunger cravings, and aid healthy weight loss.
Read More
Press Release
Aug 15, 2025
PharmaZee GLP-1 Review: Semaglutide Weight Loss Program
Telehealth-based semaglutide program offering oral and injectable options for weight management with licensed clinician support
Read More
Press Release
Aug 15, 2025
Pure Moringa Powder Review: Nature's Ultimate Superfood
Pure moringa leaf powder supports energy, digestion, and immune health using a single nutrient‑dense ingredient from MDRN Remedies.
Read More
Press Release
Aug 15, 2025
Nerve Soothe Reviews 2025: Best OTC Nerve Pain Relief?
Support nerve comfort, reduce tingling, and promote mobility with Nerve Soothe, a 2025 OTC nerve pain relief supplement backed by a 60-day money-back guarantee
Read More
Press Release
Aug 15, 2025
BookJane Partnership Announcement
BookJane and Nexim Healthcare Consultants Inc. Partner to Transform Healthcare Staffing Through Technology and Expertise
Read More
Press Release
Aug 15, 2025
BlueFletch Launches Healthcare Mobility Solution That Reduces Device Authentication Time From 30 Seconds to Under One Second
New BlueFletch Healthcare solution transforms clinical workflow efficiency while supporting healthcare organizations' regulatory compliance requirements
Read More
Press Release
Aug 15, 2025
Real Game Used Brings High-Tech & Human Expertise Together to Protect Collectors Worldwide
Read More
Press Release
Aug 15, 2025
Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona
New Arizona site represents Nutrishare's third pharmacy to support its ability to serve home TPN patients in all 50 states
Read More
Press Release
Aug 15, 2025
The Untold Truth About President Trump's Marijuana Rescheduling
The untold truth? Rescheduling may not save the cannabis industry-it could divide it. Past IRS 280E tax liabilities won't vanish-some companies owe hundreds of millions. Interstate cannabis operators still remain barred from DEA licensing, regardless of tax changes. Marijuana is still DEA regulated under the Controlled Substance Act and Quota is still the 800 pound gorilla in the room.
Read More
First
Prev
13
14
15
16
17
18
Next